Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3.
2008 Apr
Maraini, G., Williams, S.L., Sperduto, R.D., Ferris, F., Milton, R.C., Clemons, T.E., Rosmini, F., Ferrigno, L.
Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.
2004 Dec
Colevas, D., Scharf, O., Schoenfeldt, M.
Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).
2001 Sep
Colevas, A.D., West, P.J., Cheson, B.D.
Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.
2002 May
Conley, B.A., Enos, R.A., Cheson, B.D.
Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
2000 Apr
Conley, B.A., Gore-Langton, R.E., Cheson, B.D.
Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16.
2006 Apr
Clemons, T.E., Rankin, M.W., McBee, W.L.
NIH-Supported National Islet Transplantation Registry.
2004
Close, N., Anand, R., Hering, B., Eggerman, T.
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
2005 Jan
Cox, J.H., Ferrari, G., Kalams, S.A., Lopaczynski, W., Oden, N., D'souza, P.